서울특별시내과

KSN 2026 (The 46th Annual Meeting of the Korean Society of Nephrology

Name: KSN 2026 (The 46th Annual Meeting of the Korean Society of Nephrology
Start: 2026-06-11
End: 2026-06-14
Location: COEX, Seoul, Korea

6점 일반 6

주최: 대한신장학회
일자: 2026-06-11 ~ 2026-06-14 (4일)
장소: COEX, Seoul, Korea
수강료: 210,000원 구분별

수강료 구분별 상세보기

회원: 조기(120,000)/사전(150,000)/현장(180,000)
비회원: 조기(150,000)/사전(180,000)/ 현장(210,000)
Physician in training (fellow/resident): 조기(50,000)/사전(65,000)/현장(80,000)
Nurse/Paramedics/Allied Health: 조기(50,000)/사전(65,000)/ 현장(80,000)
Student(학부생, 대학원생): 조기(10,000)/사전(10,000)/현장(10,000) KSN Member (만 65세 이상 회원): 면제

원문 기준 · 정확한 등록비는 KMA 신청 페이지에서 확인하세요.

평점 구성

총 평점6점

필수평점0점

일반평점6점

연수평점은 3년 24점·연 8점 상한·필수 2점 요건이 있습니다. 이 행사 들으면 올해 상한까지 몇 점? →

KMA 등록 페이지에서 신청 → 평점 계산기

세부 일정 (311강 · 4일)

날짜를 눌러 해당 일자 프로그램을 펼쳐보세요.

Day 1 2026-06-11 (목) 69강

10:30~11:00 Salt Wasting vs SIADH: Hyponatremia with Volume Clues Room 2 (GBR 102), 1F 백선하(한림의대)
11:00~11:30 Hypokalemia Uncovered: Diagnostic Algorithm Through a Real Case Room 2 (GBR 102), 1F 조세민(중앙의대)
11:30~12:00 Uric Acid and the Kidney: What Hyperuricemia and Hypouricemia Tell Us Room 2 (GBR 102), 1F 송수현(전남의대)
13:00~13:20 Patient Fluid Balance and Net Ultrafiltration: Impacts on Survival in CKRT Patients Room 2 (GBR 102), 1F 백진혁(계명의대)
13:20~13:40 The Post-AKI Care Model: Implementing Risk-Stratified Follow-Up Room 2 (GBR 102), 1F Nuttha Lumlertgul(King Chulalongkorn Memorial Hospital, Chulalongkorn University)
13:40~14:00 Beyond Creatinine: Integrating Novel Biomarkers and Continuous Monitoring Into CKRT Weaning Protocols Room 2 (GBR 102), 1F 박요한(건양의대)
14:00~14:20 Green Nephrology in the ICU: Sustainable Practices for AKI and CKRT Management Room 2 (GBR 102), 1F 이하린(부산의대)
14:20~14:30 Group Q&A Room 2 (GBR 102), 1F -
15:00~15:30 Current Status and Future Perspectives of Medical AI Research Based on Electronic Health Records Room 2 (GBR 102), 1F 최윤재(카이스트)
15:30~16:00 Integrating AI into Nephrology: Applications and Challenges Room 2 (GBR 102), 1F Lili Chan(New York Mount Sinai Hospital)
16:00~16:30 Development and Implementation of Large Language Model in Electronic Health Records Room 2 (GBR 102), 1F 유승찬(연세대학교)
16:30~17:00 Applications of Generative AI in Clinical Practice and Medical Research Room 2 (GBR 102), 1F 전기현(서울의대)
17:40~18:30 APOL1: from Genome Discovery to Clinical Practice Auditorium, 3F Barry I. Freedman(Wake Forest University School of Medicine)
18:30~18:50 Group Q&A Auditorium, 3F -
10:30~11:00 How to Manage Complications of PD Access? Room 1 (GBR 101), 1F 강석휘(영남의대)
11:00~11:30 PD Prescription: Initial and Personalized Tailoring Room 1 (GBR 101), 1F 고강지(고려대학교 구로병원)
11:30~12:00 Management of Infectious Complications of PD: Treatment and Prevention Room 1 (GBR 101), 1F 최지영(경북의대)
13:00~13:40 Overview of MPGN: Transition from Morphological to Etiological Classification Room 1 (GBR 101), 1F Ryuji Ohashi(Nippon Medical School)
13:40~14:20 Pathological Diagnosis of Thrombotic Microangiopathy: Insights from Diverse Clinical Settings Room 1 (GBR 101), 1F 문경철(서울의대)
14:20~14:30 Group Q&A Room 1 (GBR 101), 1F -
15:00~15:40 Clinical Approach to CKD Treatment Room 1 (GBR 101), 1F 이경호(성균관의대)
15:40~16:20 A Clinical Practice on CKD Management Room 1 (GBR 101), 1F 김재영(국민건강보험 일산병원)
16:20~17:00 Treatment of CKD: Clinical Approaches and Considerations Room 1 (GBR 101), 1F 정혜진(연세의대)
10:30~10:50 CKM Syndrome: Relevance to Glomerular Disease Room 3 (GBR 103), 1F 권소이(중앙의대)
10:50~11:10 Obesity and Metabolic Dysfunction in Proteinuric GN Room 3 (GBR 103), 1F 김진숙(경희의대)
11:10~11:30 Cardiovascular Risk Stratification in Glomerular Disease Room 3 (GBR 103), 1F 박철호(연세의대)
11:30~11:50 Integrative Management Strategies for CKM in GN Room 3 (GBR 103), 1F 박세훈(서울의대)
11:50~12:00 Group Q&A Room 3 (GBR 103), 1F -
13:00~13:30 Rapid Assessment and Management of Acute Kidney Injury in the Transplant Patient Room 3 (GBR 103), 1F 신호식(고신의대)
13:30~14:00 Guideline Update: Key Points in the Care of Kidney Transplant Recipients Room 3 (GBR 103), 1F 정종철(서울의대)
14:00~14:30 Infectious Diseases After Transplant: Cutting-Edge Guidelines You Need to Know Room 3 (GBR 103), 1F 반태현(가톨릭의대)
10:30~10:50 Unmet Clinical Needs in AKI and AKD: Insights from a Nationwide Korean Multicenter Cohort Room 4 (203), 2F 안정남(한림의대)
10:50~11:10 Impact of Timing of Continuous Kidney Replacement Therapy Initiation on Clinical Outcomes Room 4 (203), 2F 민세홍(한림의대)
11:10~11:30 Pre-Initiation Urine Output as a Meaningful Determinant of Outcomes in CKRT Room 4 (203), 2F 고알아(서울의대)
11:30~11:50 Prognostic Implications of Continuous Kidney Replacement Therapy Duration in Critically Ill Patients Room 4 (203), 2F 정희연(경북의대)
11:50~12:00 Group Q&A Room 4 (203), 2F -
13:00~13:20 Multicystic Dysplastic Kidney (MCDK): Natural History and Follow-up Strategies Room 4 (203), 2F 박민지(경북의대)
13:20~13:40 Renal Hypo(dys)plasia: Prognosis and Practical Management Room 4 (203), 2F 박유진(고려대학교 구로병원)
13:40~14:00 Syndromic and Genetic CAKUT: Clinical Lessons from Case Experiences Room 4 (203), 2F 안요한(서울의대)
14:00~14:20 Growing up With CAKUT: Shaping the Future of Transition to Adult Care Room 4 (203), 2F 김정연(성균관의대)
14:20~14:30 Group Q&A Room 4 (203), 2F -
15:00~15:30 Genetic Etiology in Adult CKD in Japan Room 4 (203), 2F Eisei Sohara(Institute of Science Tokyo)
15:30~16:00 PKD Cohort Study in Korea: Clinical and Genetic Characteristics Room 4 (203), 2F 오윤규(서울의대)
16:00~16:30 Genetic Etiology of Kidney Disease in Korean Bio Big Data Room 4 (203), 2F 서고훈(3 billion)
16:30~17:00 Application of Standardized Genetic Counseling in Medical Services in Korea Room 4 (203), 2F 최인희(울산의대)
10:30~10:50 Current Status and Prognosis of Alport Syndrome in Korea(우리나라 알포트 증후군의 현황과 예후) Room 5 (205), 2F 조민현(경북의대)
10:50~11:10 Clinical Outcomes and Risk Factors of Kidney Complications Following Cancer Therapy: A Cohort-Based Study(암 치료 후 발생하는 신장 합병증 환자의 코호트 구축, 역학, 예후 분석 및 위험인자 발굴에 대한 연구) Room 5 (205), 2F 오세원(고려대학교 안암병원)
11:10~11:30 우리나라 소아청소년 및 성인 IgA 신병증의 현황과 예후에 대한 연구 Room 5 (205), 2F 김동기(서울의대)
11:30~11:50 Development of a Model for Estimating 24-Hour Urinary Sodium Excretion Using Spot Urine Samples in Korean Patients with CKD: The K-SALT Study한국인 만성콩팥병 환자의 단회 소변을 이용한 24시간 소변 소듐 배설량 추정 모델 개발: K-SALT 연구 Room 5 (205), 2F 정지용(가천의대)
13:00~13:09 (구연) Predicting Disease Activity in Childhood Nephrotic Syndrome Room 5 (205), 2F 박유진(고려대학교 구로병원)
13:09~13:18 (구연) Effects of Immunosuppressive Therapy on Cellular Aging in Kidney Transplant Recipients: an Integrative Approach Room 5 (205), 2F 박우영(계명대학교 동산병원)
13:18~13:27 (구연) Urologic Cancer Stage and Survival in Kidney Transplant Recipients: A Nationwide Comparative Cohort with Dialysis and Non-Kidney Replacement Therapy Patients Room 5 (205), 2F 강은정(서울대학교병원)
13:27~13:36 (구연) Pathophysiological Significance of Reduced Monocarboxylate Transporter (MCT) Expression in Diabetic Kidney Disease and a Novel Therapeutic Strategy through Its Restoration Room 5 (205), 2F 채승은(가톨릭대학교 인천성모병원)
13:36~13:45 (구연) Bone Turnover Markers as Independent Predictors of Bone Mineral Density Loss and Osteoporosis Beyond Parathyroid Hormone in Dialysis Patients: A 2-Year Prospective Multicenter Cohort Study Room 5 (205), 2F 김지은(고려대학교 구로병원)
13:45~13:54 (구연) Standards for Facilities and Operations of Hemodialysis Units in Korea Room 5 (205), 2F 김도형(한림대학교강남성심병원)
13:54~14:03 (구연) Decision-Making and Experiences of Conservative Kidney Management in Older Adults with Advanced Chronic Kidney Disease: A Qualitative Study Room 5 (205), 2F 송정인(동국대학교일산병원)
14:03~14:12 (구연) Green dialysis engineering: development of a water and power reduction mode for portable reverse osmosis systems in dialysis care Room 5 (205), 2F 김성근(강남세브란스병원)
14:12~14:21 (구연) The Role of Urinary Complement Factor Ba as a Biomarker for Disease Activity and Prognostic Prediction in IgA Nephropathy Room 5 (205), 2F 류세영(가톨릭대학교 인천성모병원)
14:21~14:30 (구연) Histopathologic Correlates of Kidney Function and Diagnosis in Glomerular Disease Identified Through Unsupervised Learning Room 5 (205), 2F 강민우(고려대학교 구로병원)
14:30~15:00 대한민국의 만성 콩팥병 관리제 현황과 전망 Room 5 (205), 2F 김세중(대한신장학회 등록이사)
15:00~15:30 National CKD Management Policy in Taiwan: Current Landscape and Outcomes Room 5 (205), 2F I Wen Wu(Chang Gung Memorial Hospital)
15:30~16:20 종합토론 Room 5 (205), 2F 김세중, I Wen Wu, Wei Cheng Tseng, Jin Yong Lee, Jung Min Yoo(대한신장학회 등록이사, 서울의대 의료관리학교실, 보건복지부 보험급여과장, Taipei Medical University Hospital)
13:00~13:25 Herpes Zoster Prevention in Patients With Kidney Disease: Current Evidence, Safety, and Clinical Application of the Recombinant Zoster Vaccine (RZV) Auditorium, 3F 최원석(고려대학교 안산병원)
13:25~13:50 Managing Tuberculosis Infection in End-Stage Kidney Disease: With a Focus on TB Guidelines for dialysis patients Auditorium, 3F 최지영(경북의대)
13:50~14:15 Catheter-Related Bloodstream Infections (CRBSIs): Emerging Challenges and Infection Control Implications in Dialysis and Critical Care Settings Auditorium, 3F 김형덕(가톨릭의대)
14:15~14:40 Management of Refractory or Resistant CMV Infections in Transplant Recipients: Clinical Evidence and Real-World Application of Maribavir Auditorium, 3F 고재훈(성균관의대)
15:00~15:40 Multi-Omics-Driven Precision Nephrology: from Mapping the Immune Activation Trajectory to Targeted Nanotherapy Auditorium, 3F 박세훈(서울의대)
15:40~16:20 From Genome to Precision Nephrology: Finding the Answers Auditorium, 3F Xin Sheng(Zhejiang University)
16:20~17:00 Precision Nephrology: Insights from the KPMP and the Integration of Pathology with Transcriptomics Auditorium, 3F Jeffrey Hodgin(Michigan University)

Day 2 2026-06-12 (금) 118강

08:30~08:55 Pathogenic Mechanisms of IgAN: Focusing on Mucosal B-Cell Responses Room 1 (GBR 101), 1F Hitoshi Suzuki(Juntendo University)
08:55~09:20 Precision Treatment of IgA Nephropathy: Current and Future Directions Room 1 (GBR 101), 1F Xueqing Yu(Guangdong Provincial People’s Hospital / Guangdong Academy of Medical Sciences)
09:20~09:45 Misplaced Immunity: the Role of Defective B-Cell Homing in IgAN Pathogenesis Room 1 (GBR 101), 1F Nicholas Steers(Columbia University)
09:45~10:10 The Gut-Kidney Axis in IgA Nephropathy Room 1 (GBR 101), 1F James Gleeson(Université Paris Cité)
10:20~10:45 ANCA-Associated Vasculitis: Translating Pathogenesis into Targeted Therapy Room 1 (GBR 101), 1F 박진균(서울의대)
10:45~11:10 Novel Antigens in Membranous Nephropathy: From Discovery to Clinical Integration Room 1 (GBR 101), 1F 김예림(계명의대)
11:10~11:35 Antibody-Targeted Therapies in Antigen-Defined Glomerular Diseases Room 1 (GBR 101), 1F 오세원(고려대학교 안암병원)
11:35~12:00 Future Perspectives: Antigen Discovery, Multi-Omics, and Translational Immunology Room 1 (GBR 101), 1F 김현제(서울의대)
12:50~13:40 Cardio-Kidney-Metabolic Syndrome Auditorium, 3F Peter Rossing(University of Copenhagen)
13:50~14:15 Hypertension and Cardiovascular Risk Management in Children With CKD Room 1 (GBR 101), 1F Stella Stabouli(Aristotle University of Thessaloniki)
14:15~14:40 Management of Polycystic Kidney Disease in Childhood Room 1 (GBR 101), 1F Matko Marlais(University College London)
14:40~15:05 Genetic Aspects of Renovascular Hypertension in Asian Children Room 1 (GBR 101), 1F 조희연(성균관의대)
15:05~15:30 Longitudinal Progression Trajectory of eGFR in Korean Children with CKD Room 1 (GBR 101), 1F 양은미(전남의대)
16:00~16:25 CKD and the Skin: From Common Manifestations to the Challenge of Pruritus Room 1 (GBR 101), 1F 허영(강원의대)
16:25~16:50 Sleep Disorder in CKD Room 1 (GBR 101), 1F 이유진(서울의대)
16:50~17:15 Clinical Insights on Nutrition and Sarcopenia in CKD Room 1 (GBR 101), 1F 양수진(서울여대)
17:15~17:40 Beyond the Guidelines: Tailoring Lipid Management for Optimal Outcomes in CKD Room 1 (GBR 101), 1F Rob Walker(University of Otago)
08:30~08:55 Peritoneal Dialysis in Liver Cirrhosis and Heart Failure Room 2 (GBR 102), 1F 김좌경(한림의대)
08:55~09:20 Peritoneal Dialysis in Autosomal Dominant Polycystic Kidney Disease Room 2 (GBR 102), 1F 김용철(서울의대)
09:20~09:45 Assisted Peritoneal Dialysis for Elderly ESKD Patients Room 2 (GBR 102), 1F 윤세희(건양의대)
09:45~10:10 Peritoneal Dialysis in Patients with Metabolic Syndrome Room 2 (GBR 102), 1F Sunita Bavanandan(Hospital Kuala Lumpur)
10:20~10:45 Unlocking Potassium Secretion: The Roles of Aldosterone, ROMK, and WNK Kinases Room 2 (GBR 102), 1F Biff F. Palmer(Texas Tech University Health Sciences Center)
10:45~11:10 Drug-Induced Hyperkalemia: Navigating SGLT2i, MRAs and Beyond Room 2 (GBR 102), 1F 김형덕(가톨릭의대)
11:10~11:35 Evolving Role of Potassium Binders: Evidence, Clinical Use, and Future Directions Room 2 (GBR 102), 1F 송상헌(부산의대)
11:35~12:00 Potassium Disorders and Prognosis: Lessons from CKD and Dialysis Care Room 2 (GBR 102), 1F 선인오(전주예수병원)
13:50~14:15 Emerging Biomarkers for Early Detection of Allograft Injury Room 2 (GBR 102), 1F 이정표(서울의대)
14:15~14:40 Single-Cell and Spatial Transcriptomics in Transplant Immunology Room 2 (GBR 102), 1F 이상호(강동경희대학교병원)
14:40~15:05 Machine Learning Models for Predicting Rejection and Graft Loss Room 2 (GBR 102), 1F 윤혜은(가톨릭의대)
15:05~15:30 Personalized Immunosuppression Protocols in Clinical Practice Room 2 (GBR 102), 1F 박우영(계명의대)
16:00~16:25 Human Immune Responses to Gene-Edited Pig Kidneys: Lessons from Brain-Dead Human Models and Emerging Clinical Evidence Room 2 (GBR 102), 1F Hidetaka Hara(Hainan Medical University)
16:25~16:50 Tolerance-inducing Strategies and Immunosuppression Minimization Room 2 (GBR 102), 1F 양재석(연세의대)
16:50~17:15 Transplantation in Highly Sensitized and ABO-Incompatible Recipients Room 2 (GBR 102), 1F 김효상(울산의대)
17:15~17:40 Marginal and Extended Criteria Donors: Maximizing Organ Utilization Room 2 (GBR 102), 1F 이하정(서울의대)
08:30~08:55 Place of Hemoadsorption in Sepsis-Associated AKI: Pros Room 3 (GBR 103), 1F 임성윤(서울의대)
08:55~09:20 Place of Hemoadsorption in Sepsis-Associated AKI: Cons Room 3 (GBR 103), 1F 박재윤(동국의대)
09:20~09:45 Comprehensive Management of Sepsis: Evidence-Based Updates Room 3 (GBR 103), 1F 이홍열(서울의대)
09:45~10:10 Optimal CRRT Dosing Strategy in Sepsis-Associated AKI Room 3 (GBR 103), 1F 정찬영(울산의대)
10:20~10:45 Kidney Disease and the Global NCD Agenda: Opportunities and Challenges Room 3 (GBR 103), 1F Marcello Tonelli(University of Calgary)
10:45~11:10 Therapeutic Target of Kidney Diseases: From Bench to Bedside Room 3 (GBR 103), 1F 김수완(전남의대)
11:10~11:35 Innovation in Nephrology (Telemedicine) Room 3 (GBR 103), 1F Masaomi Nangaku(University of Tokyo)
11:35~12:00 Management of CKD: Lessons from a Nationwide Korean Cohort Room 3 (GBR 103), 1F 오국환(서울의대)
13:50~14:15 New Drugs for ANCA Vasculitis Treatment Room 3 (GBR 103), 1F Vladimír Tesař(Charles University in Prague)
14:15~14:40 ANCA-Associated Vasculitis Reading Between the Lines Room 3 (GBR 103), 1F Silke Brix(University of Hamburg)
14:40~15:05 Koreas Experience of Avacopan Treatment Room 3 (GBR 103), 1F 김성미(가톨릭의대)
15:05~15:30 Older Age and Frailty in ANCA-Vaculitis Room 3 (GBR 103), 1F 권소이(중앙의대)
16:00~16:25 Preserving Peritoneal Membrane Function Room 3 (GBR 103), 1F Isaac Teitelbaum(University of Colorado Hospital)
16:25~16:50 Preventing Infections in PD Room 3 (GBR 103), 1F 임정훈(경북의대)
16:50~17:15 Addressing PD Patient and Caregiver Burnout: Assisted PD Room 3 (GBR 103), 1F Kelly Lim(Tan Tock Seng Hospital)
17:15~17:40 Troubleshooting the PD Catheter Room 3 (GBR 103), 1F 김형덕(가톨릭의대)
08:30~08:55 Hemodialysis: High Flux, High Footprint? Room 4 (203), 2F Jane Waugh(Sunshine Coast University Private Hospital)
08:55~09:20 Peritoneal Dialysis: Plastic Bags and Green Promises Room 4 (203), 2F Cheuk-Chun Szeto(The Chinese University of Hong Kong)
09:20~10:00 Smart Dialysis Engineering: Cutting Energy, Waste, and Water Room 4 (203), 2F 김성근(연세의대)
10:00~10:10 Group Q&A Room 4 (203), 2F -
10:20~10:40 Intracranial Aneurysms in ADPKD: Updated Screening and Management in the KDIGO 2025 Era : Real-World Practice in Japan Room 4 (203), 2F Yusuke Ushio(Tokyo Womens Medical University)
10:40~11:00 Beyond the Cysts: The Hidden Prognostic Value of Muscle Mass and BMI in ADPKD Room 4 (203), 2F 김용철(서울의대)
11:00~11:20 Beyond Tolvaptan: Combination Strategies to Further Suppress Kidney Volume Growth in ADPKD Room 4 (203), 2F Shinya Nakatani(Osaka Metropolitan University Graduate School of Medicine)
11:20~11:40 Effectiveness of Abdominal Bracing Core Exercises As Rehabilitation Therapy for Reducing Abdominal Symptoms in Patients with Autosomal Dominant Polycystic Kidney Disease and Significant Polycystic Liver Disease Room 4 (203), 2F 김현숙(한림의대)
11:40~11:50 Q&A Room 4 (203), 2F -
13:50~14:15 What Are the Differences Between Hypertension Guidelines? Room 4 (203), 2F 정성진(가톨릭의대)
14:15~14:40 Resistant Hypertension: Latest Insights and Management Strategies Room 4 (203), 2F 박성하(연세의대)
14:40~15:05 New Drugs in Hypertension Room 4 (203), 2F 이하린(부산의대)
15:05~15:30 Trending Issues in Hypertension: Research Recommendations for the Young Investigators Room 4 (203), 2F 강시혁(분당서울대병원)
16:00~16:25 Population-Based Trends in Dialysis Incidence and Prevalence in Korea: Analysis of HIRA Data(우리나라 투석 환자 발병률 및 유병률 변화) Room 4 (203), 2F 이하정(서울의대)
16:25~16:50 Redesigning the ESKD Registry: Vision and Roadmap(말기신부전 등록사업 개편 및 향후 계획) Room 4 (203), 2F 김기표(분당차병원)
16:50~17:15 2026 Hemodialysis Unit Accreditation Report(2026년 인공신장실 인증평가 보고) Room 4 (203), 2F 김좌경(한림의대)
17:15~17:40 PD Home Care Pilot Program(복막투석 재택관리 시범사업 보고) Room 4 (203), 2F 신호식(고신의대)
08:30~08:40 (구연) Inhibition Of Core Fucosylation By 2-Fluorofucose Attenuated Acute Kidney Injury By Modulating ERK1/2 Signaling Axis. Room 5 (205), 2F Nan Shen(The 1st Affiliated Hospital of Dalian Medical University)
08:40~08:50 (구연) Cuffless Ring Photoplethysmography for 24-Hour Blood Pressure Monitoring in Hemodialysis Patients: Validation Against Ambulatory BP Monitoring and Assessment of Dipping Pattern Agreement Room 5 (205), 2F Jong Hyun Jhee(강남세브란스병원)
08:50~09:00 (구연) The Ang2/Ang1 Ratio as an Independent Predictor of MACE in Hypertensive CKD Patients Room 5 (205), 2F 김지영(중앙대학교병원)
09:00~09:10 (구연) FAST-DEC multimodal deep clustering identifies reproducible ICU acute kidney injury subphenotypes and a phenotype-specific benefit of early kidney replacement therapy Room 5 (205), 2F Min Woo Kang(고려대학교 구로병원)
09:10~09:20 (구연) Time-Varying Mortality Risk of Metabolic Syndrome in CKRT Patients: A Nationwide Cohort Study Room 5 (205), 2F Minji Kim(삼성서울병원)
09:20~09:30 (구연) Long-term Kidney Outcomes After Immune Checkpoint Inhibitor Therapy Compared With Conventional Chemotherapy Room 5 (205), 2F Inyong Jeong(고려대학교)
09:30~09:40 (구연) DEvelopment of a mode-Change-based strategy for dIScontInuation during ONgoing CKRT (DECISION-CKRT): A Multicenter Prospective Observational Study Room 5 (205), 2F 박요한(건양대학교병원)
09:40~09:50 (구연) Differential Effects of SGLT2 Inhibitors on Contrast-Associated Acute Kidney Injury According to Hemoglobin and Age: A Propensity-Score Matched Analysis Room 5 (205), 2F Byungkwan Jung(가천대길병원)
09:50~10:00 (구연) Comparative efficacy and safety of therapies for syndrome of inappropriate antidiuresis-associated hyponatremia: A systematic review and network meta-analysis Room 5 (205), 2F Joseph Paulo Gonzales(University of the Philippines Manila - Philippine General Hospital)
10:00~10:10 (구연) Evaluation of Longitudinal Plasma and Urinary Biomarkers for Predicting Acute Kidney Disease in Patients with Sepsis-Associated Acute Kidney Injury: A Prospective Cohort Study Room 5 (205), 2F Ha-Eun Lee(예수병원)
10:20~10:30 (구연) Single-Cell Transcriptomic and Clonal Profiling Reveals Shared Signatures of Gd-IgA1 Stratification and B-Cell Clonal Expansion in IgA Nephropathy Room 5 (205), 2F Jinsun Lee(서울대학교 의과대학)
10:30~10:40 (구연) Soluble CD93 Mediates Podocyte Injury Through Activation of the TGF- Pathway in Idiopathic Nephrotic Syndrome Room 5 (205), 2F Md Imtiazul Islam(Nationwide Childrens Hospital)
10:40~10:50 (구연) Moderate-to-Vigorous Aerobic Exercise Improves Outcomes in IgA Nephropathy through Remodeling of Clinical Parameter Interactions and Metabolic Networks Room 5 (205), 2F Jiaxing Tan(West China Hospital of Sichuan University)
10:50~11:00 (구연) Dysregulated B-cell T-cell Interactions in Immune Mediated Glomerular Diseases Room 5 (205), 2F Jenna Simpson(Columbia University Irving Medical Center)
11:00~11:10 (구연) Genetic latent factor-aided identification of protein targets to prioritize drug repurposing candidates for primary membranous nephropathy Room 5 (205), 2F Woo Vin Lee(서울대학교)
11:10~11:20 (구연) Unbiased Transcriptomic Clustering Identifies a STAT1-Driven Inflammatory PEC Endotype at the Glomerular Vascular Pole Room 5 (205), 2F Jeong Ho Joo(한국과학기술원)
11:20~11:30 (구연) Single-Cell Transcriptomics Identifies CD8 T-Cell Differentiation Signatures in Early IgA Nephropathy Room 5 (205), 2F Soojin Lee(을지대학교병원)
11:30~11:40 (구연) Serum PLA2R Antibody to Total IgG Ratio Predicts Response to CD20 Monoclonal Antibody Therapy in PLA2R-Positive Membranous Nephropathy Room 5 (205), 2F Kaiyuan Zheng(Banan Hospital of Chongqing Medical University)
11:40~11:50 (구연) Analysis of IgA+ B-cells, IgA, and Gd-IgA1 in Monozygotic Twins Discordant for IgA Nephropathy Room 5 (205), 2F Suh Yeon Oh(Columbia University Irving Medical Center)
11:50~12:00 (구연) Integrated Peripheral and Spatial Single-Cell Multiomics Reveals Immune Remodeling in Minimal Change Disease Room 5 (205), 2F Hyunah Ku(서울대학교 의과대학)
13:50~14:00 (구연) Drug screening using human kidney organoid for autosomal dominant polycystic kidney disease enabled the effective drug repurposing Room 5 (205), 2F Jeongeun Lee(가톨릭대학교 가톨릭중앙의료원)
14:00~14:10 (구연) Cell death and inflammation in the progression of cystic kidney disease Room 5 (205), 2F Emilia Kieckhoefer(CECAD University of Cologne Cologne Germany)
14:10~14:20 (구연) Pathological Tau Accumulation Contributes to Tubulointerstitial Injury and Fibrosis in Chronic Kidney Disease Room 5 (205), 2F Seong Woo Lee(순천향대학교 천안병원)
14:20~14:30 (구연) Gut microbiome remodeling across CKD etiologies reveals ecological imbalance signatures linked to kidney injury Room 5 (205), 2F Minjie Fu(서울대학교병원)
14:30~14:40 (구연) Dapagliflozin attenuates PM2.5-induced renal tubular cell injury via modulation of EGR-1 and MAPK signaling pathways. Room 5 (205), 2F Hyung Eun Yim(고려대학교 안산병원)
14:40~14:50 (구연) Fabry Disease Is Ameliorated by Long-Term PEG-Capped Ceria-Zirconia Nanoparticles via GSK3beta-TFEB-Mediated Restoration of Cholesterol Homeostasis Room 5 (205), 2F Eun Kyung Kim(건양대학교병원)
14:50~15:00 (구연) A Large-Scale Single-Nucleus Transcriptomic Landscape of Major Human Glomerular Diseases Room 5 (205), 2F 고알아(서울대학교병원)
15:00~15:10 (구연) Proximal Tubular ALOX5 Links ECM Homeostasis and Collagen Remodeling in Renal Fibrosis Room 5 (205), 2F Youngyoon Moon(강동경희대학교병원)
15:10~15:20 (구연) Generation of the functionally matured human ureteric bud organoids with the enhanced branching morphogenesis Room 5 (205), 2F Sua Kim((주)알젠오가노 바이오테크놀로지)
15:20~15:30 (구연) A single-cell-resolution spatial transcriptomic atlas of human glomerular diseases Room 5 (205), 2F Jae-Ik Oh(서울대학교 의과대학)
16:00~16:10 (구연) External Validation And Recalibration Of International Prognostic Models For Chronic Kidney Disease In The KNOW-CKD Room 5 (205), 2F Sangjun Lee(서울대학교 의과대학)
16:10~16:20 (구연) Evaluating LLM Agents vs. Human Responses in a Nephrology OSCE Scenario: A Human-Rated Dialogue Analysis Room 5 (205), 2F Yongjin Yi(단국대학교병원)
16:20~16:30 (구연) Sleep disorder and health related quality of life in pediatric chronic kidney disease Room 5 (205), 2F Dina Ebrahem Sallam(Faulty of Medicine Ain Shams University Egypt)
16:30~16:40 (구연) Epidemiology and longitudinal change in renal involvement in pediatric patients with Tuberous sclerosis Complex: A single-center retrospective study Room 5 (205), 2F Seon Hee Lim(부산대학교병원)
16:40~16:50 (구연) Distinct Immune Signatures of Steroid Responsiveness in Childhood Nephrotic Syndrome Room 5 (205), 2F Peong Gang Park(세브란스병원)
16:50~17:00 (구연) Association of Estimated Glomerular Filtration Rate-Adjusted Proteinuria with Kidney Failure in Older Patients with Moderate-to-Severe CKD Room 5 (205), 2F 김성미(가톨릭대학교 은평성모병원)
17:00~17:10 (구연) Residential Instability and Clinical Outcomes in Older Adults With Chronic Kidney Disease: A Multicenter Prospective Cohort Study Room 5 (205), 2F Jin Kyung Kwon(계명대학교 동산병원)
17:10~17:20 (구연) Evaluation of artificial intelligence in diagnosing sarcopenia and predicting mortality in patient with chronic kidney disease Room 5 (205), 2F Ju Young Lee(강북삼성병원)
17:20~17:30 (구연) Association between Polypharmacy-related Peripheral Edema and Functional Decline in Elderly Patients with Chronic Kidney Disease (CKD): A 3-Year Follow-up Study Room 5 (205), 2F Jung Hwa Ryu(이화여자대학교 서울병원)
17:30~17:40 (구연) Comparison of eGFR Discordance Metrics for Predicting Activities of Daily Living Dependence in Older Adults With Chronic Kidney Disease Room 5 (205), 2F Sojung Youn(가톨릭대학교 부천성모병원)
08:30~08:55 Malignancy in Hemodialysis Patients: Monitoring and Management Auditorium, 3F Takeshi Matsubara(Kitano Hospital)
08:55~09:20 Atrial Fibrillation in Hemodialysis: Risks, Anticoagulation, and Clinical Outcomes Auditorium, 3F Szu-Chun Hung(Taipei Tzu Chi Hospital)
09:20~09:45 Dialyzer Selection and Its Clinical Implications Auditorium, 3F 임정훈(경북의대)
09:45~10:10 Depression in Hemodialysis Patients Auditorium, 3F Yoichi Otake(Takeo Medical Clinic)
10:20~10:45 Why CKM Matters in Nephrology: The Expanding Burden of Kidney Disease Auditorium, 3F 이정환(서울의대)
10:45~11:10 Unlocking Treatment in Non-DM and T1DM CKD: New Finerenone Evidence for High Unmet Needs Auditorium, 3F 이정은(성균관의대)
11:10~11:35 From Kidney to Heart: Finerenone’s Expanding Role in Comprehensive CKM Treatment Auditorium, 3F Brendon Neuen(University of Sydney)
11:35~12:00 Panel Discussion Auditorium, 3F 이정환 이정은 Brendon Neuen 김성근 고강지(서울의대 성균관의대 University of Sydney 연세의대 고려의대 구로병원)
13:50~14:50 Local Evidence: Clinical Implications of Phase 3 Trials and the Therapeutic Value of Vadanem in Korea Auditorium, 3F 정성진(가톨릭의대)
14:50~15:20 Panel Discussion (Speakers) & Q&A Auditorium, 3F
16:00~16:50 Kidney Disease Patient Advocacy Session: Insight Group Discussion 1 Auditorium, 3F 유성호 황원민 박지현(서울의대 건양의대 국립경찰병원)
16:50~17:40 Kidney Disease Patient Advocacy Session: Insight Group Discussion 2 Auditorium, 3F 김미영 이상열 김준환 이동형(제1형 당뇨병 환우회 경희의대 카카오 헬스케어 범일연세내과)

Day 3 2026-06-13 (토) 98강

08:30~08:55 Preserving Mobility and Cognition in Elderly CKD Patients: Community-Based Strategies from Japan Room 1 (GBR 101), 1F Kazuhiko Tsuruya(Nara Medical University)
08:55~09:20 Conservative Kidney Care for the Elderly in Japan: Redefining Choice, Dignity, and Outcomes Room 1 (GBR 101), 1F Yugo Shibagaki(St Marianna University)
09:20~09:45 Addressing the Challenges of Chronic Kidney Disease in Korea’s Super-Aged Population: Policy Perspectives Room 1 (GBR 101), 1F 이상범(서울신내의원)
09:45~10:10 Q&A Room 1 (GBR 101), 1F -(-)
10:20~11:10 Xenotransplantation: Clinical Development and Challenges Auditorium, 3F Tatsuo Kawai(Harvard Medical School)
11:10~11:40 Panel Discussion Auditorium, 3F 민상일, Hidetaka Hara, 양재석(서울의대, Hainan Medical University, 연세의대)
13:00~13:20 Policy Options for the Prevention and Progression Control of Diabetic Kidney Disease Room 1 (GBR 101), 1F 김효진(고려대학교 구로병원)
13:20~13:40 Strategies to Promote Peritoneal Dialysis: Focus on International Cases Room 1 (GBR 101), 1F Adrian Liew(Mount Elizabeth Novena Hospital)
13:40~14:00 Unique Indications for Home Hemodialysis Room 1 (GBR 101), 1F Masaki Hara(Tokyo Frontier Group)
14:00~14:30 Home Dialysis Patient Experience Sharing: Taiwan Room 1 (GBR 101), 1F Hung-Lai Wu(Peritoneal Dialysis Patient Association of R.O.C)
14:30~15:00 Panel Discussion Room 1 (GBR 101), 1F Chia-Ter Chao, 김좌경, Jia-Jung Lee(National Taiwan University Hospital, 한림의대, Kaohsiung Medical University Hospital, Kaohsiung Medical University )
15:30~16:00 SLE Treatment Updates and Current Option in Asia Pacific Region Room 1 (GBR 101), 1F Sharon Ford(Austin Health, Heidelberg, Victoria, Australia)
16:00~16:30 Acute Kidney Injury: Novel Therapeutics and Beyond Room 1 (GBR 101), 1F Desmond Yap(Queen Mary Hospital)
16:30~17:00 Diabetic Kidney Disease: Bridging Clinical Guidelines and Real-World Care Room 1 (GBR 101), 1F Jia Liang Kwek(Singapore General Hospital)
17:00~17:30 Post KT Management Int the CKM Syndrome Era Room 1 (GBR 101), 1F 강은정(서울의대)
08:30~08:55 The AKI-to-CKD Transition: Unraveling the Role of Cellular Senescence and Maladaptive Repair Room 2 (GBR 102), 1F 이정환(서울의대)
08:55~09:20 Sepsis-Associated AKI: Differentiating Clinical Phenotypes for Targeted Therapeutic Strategies Room 2 (GBR 102), 1F 임성윤(서울의대)
09:20~09:45 The Kidney in Dialogue: Understanding AKI-induced Inter-organ Crosstalk and Systemic Consequences Room 2 (GBR 102), 1F 강동혁(가톨릭의대)
09:45~10:10 Evaluating the Effectiveness of AKI Prediction Models Room 2 (GBR 102), 1F 김세중(서울의대)
13:00~13:30 AI in Hemodialysis에 대한 전반적인 Review Room 2 (GBR 102), 1F 이예하(뷰노)
13:30~14:00 AI를 이용한 혈액투석중 저혈압 예측 Room 2 (GBR 102), 1F 김세중(분당서울대병원)
14:00~14:30 Precision Anemia Management in Hemodialysis: From Algorithm Development to Randomized Controlled Trial(AI를 이용한 혈액투석 환자의 빈혈 치료) Room 2 (GBR 102), 1F 윤해룡(연세의대)
14:30~15:00 Artificial Intelligence for Prediction and Management of CKD-MBD(AI를 이용한 CKD-MBD 예측과 치료) Room 2 (GBR 102), 1F 윤혜은(가톨릭의대)
15:30~15:50 Sarcopenic Obesity in CKD: from Pathophysiology to Clinical Outcomes. Room 2 (GBR 102), 1F Csaba Kovesdy(The University of Tennessee)
15:50~16:10 Optimizing Weight: Balancing CVD and Sarcopenia Risks Room 2 (GBR 102), 1F 정수웅(강동경희대학교병원)
16:10~16:30 Healthy Diets in CKD: Harnessing Potassium Room 2 (GBR 102), 1F Connie Rhee(David Geffen School of Medicine at UCLA)
16:30~16:50 Nutritional Support for Sarcopenia Prevention Among CKD Patients Room 2 (GBR 102), 1F 김해림(충북의대)
16:50~17:10 Nutrition Management in CKD: The Role of Clinical Dietitians in Reducing Ultra-Processed Food Intake Room 2 (GBR 102), 1F 김아람(가톨릭의대)
17:10~17:30 Group Q&A Room 2 (GBR 102), 1F -
08:30~08:55 The Latest Hypertension Guideline Room 3 (GBR 103), 1F 박재형(충남의대)
08:55~09:20 Obstructive Sleep Apnea in Hypertension and CKD Room 3 (GBR 103), 1F 나진오(고려대학교 구로병원)
09:20~09:45 Aldosterone Synthase Inhibitors in Development: Current and Upcoming Data Room 3 (GBR 103), 1F Jamie P. Dwyer(University of Utah)
09:45~10:10 RNA Interference: A Novel Strategy in the Management of Hypertension Room 3 (GBR 103), 1F 박철호(연세의대)
13:00~13:30 GLP-1/GIP Agonists for Obesity in CKD Room 3 (GBR 103), 1F 손장원(가톨릭의대)
13:30~14:00 GLP-1/GIP Agonists for Diabetic Kidney Disease Room 3 (GBR 103), 1F 김남훈(고려대학교 안암병원)
14:00~14:30 Dyslipidemia Management in CKD: Latest Guidelines Room 3 (GBR 103), 1F 서상헌(전남의대)
14:30~15:00 The Metabolic Syndrome and Risk of Chronic Kidney Disease Room 3 (GBR 103), 1F 주영수(연세의대)
15:30~16:00 Current Diagnostic Strategies and Unmet Therapeutic Needs in C3G and primary IC-MPGN Room 3 (GBR 103), 1F Nicholas Webb(Head of Nephrology Clinical Strategy SobiHonorary Professor of Paediatric Nephrology, University of Manchester UK)
16:00~16:30 Pegcetacoplan: Results of the VALIANT Trial and Real-World Experience Room 3 (GBR 103), 1F 한승혁(연세의대)
16:30~16:40 Q&A Room 3 (GBR 103), 1F -
16:40~17:30 International Case Studies of Home-Based Management(재택관리 해외사례) Room 3 (GBR 103), 1F 김성균(한림의대)
08:30~08:55 Japanese Kidney Disease Registry and Cohort Study Room 4 (203), 2F Nishibori Nobuhiro(Nagoya University)
08:55~09:20 The Hong Kong Renal Registry Room 4 (203), 2F John YH Chan(Queen Elizabeth Hospital)
09:20~09:45 KNOW-CKD: Building Evidence Through a Prospective CKD Cohort Room 4 (203), 2F 주영수(연세의대)
09:45~10:10 ANZDATA – Using Registry Data to Drive Change Room 4 (203), 2F Stephen McDonald(ANZDATA Registry)
13:00~13:30 Collaboration Between Emergency Physicians and Nephrologists in the War Situation Room 4 (203), 2F 정주(분당서울대병원)
13:30~14:00 Earthquake Preparedness for Healthcare Professionals Room 4 (203), 2F 홍태경(연세대학교)
14:00~14:30 Climate-Related Disasters and Heat-Related Illness: Implications for Kidney Patients Room 4 (203), 2F 문성배(경북의대)
14:30~15:00 Korean Society of Nephrology Disaster Response Committee: Progress and Future Directions Room 4 (203), 2F 유경돈(울산의대)
15:30~15:55 당뇨병콩팥병의 현황, 진단 및 신장전문의 협진 Room 4 (203), 2F 최종욱(한양의대)
15:55~16:20 Non-Pharmacological and Pharmacological Management of Diabetic Kidney Disease(당뇨병콩팥병의 비약물 및 약물 치료) Room 4 (203), 2F 고은실(가톨릭의대)
16:20~16:45 Comprehensive Management of Diabetic Kidney Disease and Associated Complications(당뇨병콩팥병의 포괄 치료 및 합병증 관리) Room 4 (203), 2F 박거늘(순천향의대)
16:45~17:10 Renal Replacement Therapy in Diabetic Kidney Disease(당뇨병콩팥병의 콩팥대체요법) Room 4 (203), 2F 류지원(서울의대)
17:10~17:30 소아청소년 당뇨병콩팥병의 관리 Room 4 (203), 2F 이현경(중앙의대)
08:30~08:40 (구연) Long-Term Effects of Combined Super High-Flux and Medium-Flux Dialysis on Middle-Molecule Levels and Sleep Quality in Maintenance Hemodialysis: A Prospective Longitudinal Cohort Study Room 5 (205), 2F Tran Tuan Tu(thainguyen university of Medicine and pharmacy)
08:40~08:50 (구연) Central Venous Catheter As Permanent Vascular Access Should Be Avoided Even In The Oldest-old Population Undergoing Dialysis: A Nationwide Cohort Study Room 5 (205), 2F Jooun Park(가톨릭대학교 서울성모병원)
08:50~09:00 (구연) Multi-Organ POCUS Revealing High Flow Arteriovenous Fistula-Related Pulmonary Hypertension Room 5 (205), 2F 김은정(한림대학교동탄성심병원)
09:00~09:10 (구연) Clonal hematopoiesis of indeterminate potential and cardiovascular outcomes in patients undergoing maintenance hemodialysis Room 5 (205), 2F Baek Jihyun(차의과학대학교 분당차병원)
09:10~09:20 (구연) Real-Time Optimization of Ultrafiltration and Blood Flow Rate in Hemodialysis Using Offline Reinforcement Learning Room 5 (205), 2F Min Woo Kang(고려대학교 구로병원)
09:20~09:30 (구연) Economic Value of Reducing End-stage Kidney Diseases in 45 Countries, 2015-2023, with Projections up to 2050: A Global Modeling Study Room 5 (205), 2F Jeong-Yeun Lee(경희의료원)
09:30~09:40 (구연) Real-World Outcomes of COVERA Stent Graft for Venous Anastomosis Stenosis in Arteriovenous Grafts: A Single-Center Experience Room 5 (205), 2F 구상건(생명선의원)
09:40~09:50 (구연) Continuous Intradialytic ECG Surveillance Reveals AF/AFL Burden and Mortality Risk in Hemodialysis Room 5 (205), 2F Donghwan Yun(서울대학교병원)
09:50~10:00 (구연) Maturation Outcomes of Arteriovenous Fistula Versus Graft: A Multicenter Prospective Registry Study Room 5 (205), 2F Chang Min Park(가톨릭대학교 의정부성모병원)
10:00~10:10 (구연) Serial Metabolic Changes and Peritoneal NAMPT as Predictors of Peritonitis in Peritoneal Dialysis: A 5-Year Prospective Cohort Study Room 5 (205), 2F Seonha Lee(고려대학교 안산병원)
13:00~13:10 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Joon Young Jang(연세대학교 의과대학)
13:10~13:20 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Jeeyoung Yoon(가톨릭대학교 서울성모병원)
13:20~13:30 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F 김지영(중앙대학교병원)
13:30~13:40 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Seyoung Ryou(가톨릭대학교 인천성모병원)
13:40~13:50 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F 정혜진(연세대학교 의과대학)
13:50~14:00 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Soo-Young Yoon(경희의료원)
14:00~14:10 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Heajung Lee(연세대학교)
14:10~14:20 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Seunghyeok Choi(전북대학교병원)
14:20~14:30 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Jeong-Yeun Lee(경희의료원)
14:30~14:40 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F 최성은(국민건강보험 일산병원)
14:40~14:50 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Hojin Lee(고려대학교 안암병원)
14:50~15:00 (구연) Selective Depletion of ABO-Specific B Cells by T Cell-Engaging Bispecific Antibody Conjugates for ABO-Incompatible Kidney Transplantation Room 5 (205), 2F Omi Na(세브란스 병원)
15:30~15:39 (구연) Characteristics of Dietary Sodium Intake Assessed by 24-Hour Urine Collection in Korean Patients with Chronic Kidney Disease: Insights from the K-SALT Study Room 5 (205), 2F Woo-Yeong Park(계명대학교 동산병원)
15:39~15:48 (구연) Elucidating the Genetic Landscape of End-Stage Renal Disease: Genome-Wide Association and Multi-Polygenic Risk Score Analyses Room 5 (205), 2F Omi Na(세브란스병원)
15:48~15:57 (구연) The K-SALT Equation: Development and Validation of a Population-Specific Formula for Estimating 24-Hour Urinary Sodium Excretion in Korean Patients With Chronic Kidney Disease Room 5 (205), 2F 조세민(중앙대학교 광명병원)
15:57~16:06 (구연) Development and Validation of East Asian equation to predict 24hr urine creatinine excretion: Analysis of The KNOW-CKD study Room 5 (205), 2F Eun Mi You(분당서울대학교병원)
16:06~16:15 (구연) Differential impact of chronic kidney disease on the risk of ischemic versus hemorrhagic stroke Room 5 (205), 2F Da Woon Kim(부산대학교병원)
16:15~16:24 (구연) Long-Term Effects of Ambient Ozone on Mortality and Cardiovascular Outcomes in a Nationwide Cohort of Over One Million Patients with Chronic Kidney Disease Room 5 (205), 2F Seung Hyun Han(인제대학교 일산백병원)
16:24~16:33 (구연) Sustained Diastolic Dysfunction and the Risk of eGFR Decline in CKD Patients with the Pre-HFpEF Phenotype: Application of the Parametric G-Formula Room 5 (205), 2F 고알아(서울대학교병원)
16:33~16:42 (구연) Attenuation of Renal Lipotoxicity via Restoration of Autophagy Flux through PI3K/AKT-GSK3beta-TFEB Signaling by Copper Oxide Nanoparticles Room 5 (205), 2F Eun Kyung Kim(건양대학교병원)
16:42~16:51 (구연) Decomposing the Cardiovascular Event Disparity Between U.S. and Korean Chronic Kidney Disease Patients : A Blinder-Oaxaca Analysis of CRIC and KNOW-CKD Cohorts Room 5 (205), 2F Ye Eun Ko(용인세브란스병원)
16:51~17:00 (구연) Distinct Hemoglobin Trajectories and Their Prognostic Implications in Chronic Kidney Disease: Findings from the KNOW-CKD Cohort Room 5 (205), 2F 조세민(중앙대학교 광명병원)
17:00~17:09 (구연) Finerenone Reduces Urinary Biomarkers of Tubular Injury and Mitochondrial Stress Independent of Albuminuria Response Room 5 (205), 2F Kootae Park(순천향대학교 구미병원)
17:09~17:18 (구연) Association between Skeletal Muscle Mass and Clinical Outcomes of Chronic Kidney Disease Room 5 (205), 2F Miso Ha(서울대학교병원)
17:18~17:27 (구연) Genetic and Lipoproteomic Evidence for a Non-Albuminuric Pathway to Kidney Failure Driven by LCAT Dysfunction Room 5 (205), 2F Wencheng Jin(Ningbo No.2 Hospital, Ningbo, China)
13:00~13:20 Guideline Updates: Evolving Standards in DKD Care Auditorium, 3F Ian de Boer(University of Washington, Seattle)
13:20~13:40 Incretin-Based Therapies: Add on as Needed or Fourth Pillar for Managing Diabetic Kidney Disease? Auditorium, 3F Merlin Thomas(Monash University)
13:40~14:00 Next-Generation Aldosterone Pathway Inhibitors Auditorium, 3F Masaomi Nangaku(University of Tokyo)
14:00~14:20 Emerging Anti-Inflammatory and Novel Pathway-Targeted Therapies Auditorium, 3F 차진주(고려대학교 안산병원)
14:30~15:00 Panel Discussion Auditorium, 3F Sydney C. W. Tang, 문주영, 김형래, 이은정(University of Hong Kong, Queen Mary Hospital, 경희의대, 순천향의대, 성균관의대)
15:30~16:00 Ethical Issue of Hemodialysis Center (윤리성평가의 실제) Auditorium, 3F 이재원(지샘병원)
16:00~16:30 의료윤리 관점에서 AI 헬스케어 Auditorium, 3F 김준혁(연세대학교)
16:30~17:00 AI in Healthcare: Current Trends and Ethical Issues (보건의료 AI 도입 현황 및 윤리적 시사점 ) Auditorium, 3F 박소연(인하의대)
17:00~17:30 AI in Nephrology: Ethical Challenges and Data Responsibilities in the Digital Age(AI 시대에 신장내과 의사의 의료 윤리) Auditorium, 3F 신성준(동국의대)

Day 4 2026-06-14 (일) 26강

08:30~09:00 Assessing and Improving Dialysis Adequacy for Optimizing Peritoneal Dialysis(복막투석 치료 최적화를 위한 투석적절도 평가 및 개선전략) Room 1+2 (GBR 101+102), 1F 전준석(삼성서울병원)
09:00~09:30 Resoving possible complications and problems during peritoneal dialysis treatment(복막투석치료 중 발생 가능한 합병증 및 문제해결 방안) Room 1+2 (GBR 101+102), 1F 차경숙(가톨릭의대)
09:30~10:00 Recognizing Laboratory Changes and Clinical Warning Signs in Dialysis Patients(투석 환자의 검사 수치 변화와 임상경고 신호 감별) Room 1+2 (GBR 101+102), 1F 박혜인(한림의대)
10:00~10:30 환자중심 투석 교육 컨텐츠 개발 Room 1+2 (GBR 101+102), 1F 박민욱(삼성서울병원)
10:40~11:10 Contemporary Management of Hemodialysis Vascular Access: From Successful Creation to Ensuring Long-term Patency (혈액투석을 위한 혈관 접근로의 성공적 형성과 기능 보존을 위한 최신 관리 방안) Room 1+2 (GBR 101+102), 1F 최선령(경기도의료원 수원병원)
11:10~11:40 A Standardized Nursing Approach for Safe Arteriovenous Fistula Cannulation (안전한 동정맥루 천자를 위한 표준화된 간호접근) Room 1+2 (GBR 101+102), 1F 김덕임(노원을지대학교병원)
11:40~12:10 Complication During Hemodialysis and Emergency Management(투석 중 발생 가능한 합병증과 응급대처법) Room 1+2 (GBR 101+102), 1F 최은아(서울아산병원)
12:10~12:40 Nutritional Assessment and Management in Dialysis Patients(투석환자의 영양평가 및 영양관리) Room 1+2 (GBR 101+102), 1F 박유경(한림의대)
09:00~10:30 Hands On Session Class 1: Vascular Access US, Simulator (Vascular access BFR,Kidney Biopsy,Catheter Insertion,AVF ,PTA),Lung US,IVC US,VExUS (Hepatic Vein, Portal Vein),Kidney US Room 201-202, 2F 김철수,구상건,이동희,박훈석,김형덕,이한비, 함영록,김인수,이정환,최광호,이형석,김은정,김도형(김철수 내과 의원,생명선의원,안양샘병원,가톨릭의대,가톨릭의대,가톨릭대학교 서울성모병원,충남의대,김영옥 성모내과 의원,서울의대,춘천성심병원,한림의대,한림의대 동탄성심병원,한림대학교강남성심병원)
10:50~12:20 Hands On Session Class 2: Vascular Access US, Simulator (Vascular access BFR,Kidney Biopsy,Catheter Insertion,AVF ,PTA),Lung US,IVC US,VExUS (Hepatic Vein, Portal Vein),Kidney US Room 201-202, 2F 김철수,구상건,이동희,박훈석,김형덕,이한비, 함영록,김인수,이정환,최광호,이형석,김은정,김도형(김철수 내과 의원,생명선의원,안양샘병원,가톨릭의대,가톨릭의대,가톨릭대학교 서울성모병원,충남의대,김영옥 성모내과 의원,서울의대,춘천성심병원,한림의대,한림의대 동탄성심병원,한림대학교강남성심병원)
08:30~09:00 Fluid and Blood Pressure Management in Hemodialysis Room 3 (GBR 103), 1F 황진호(중앙의대)
09:00~09:30 Heart Failure and Pulmonary Congestion in Dialysis Patients Room 3 (GBR 103), 1F 조은정(중앙의대)
09:30~10:00 Very Old ESRD Patients: Hemodialysis Versus Palliative Room 3 (GBR 103), 1F 박요한(건양의대)
10:00~10:30 Infection Prevention and Vaccination Strategies in the Dialysis Unit Room 3 (GBR 103), 1F 이장욱(동국대학교일산병원)
10:40~11:10 Point-of-Care Ultrasound for Nephrologists: from Access to Volume Room 3 (GBR 103), 1F 김은정(한림의대 동탄성심병원)
11:10~11:40 Ensuring Quality in Hemodialysis: from Adequacy to Outcomes Room 3 (GBR 103), 1F 조아진(건국대학교병원)
11:40~12:10 Green Dialysis: Reducing Waste and Water Consumption Room 3 (GBR 103), 1F 차진주(고려대학교 안산병원)
12:10~12:40 Anemia Management in 2026: Beyond ESA and Iron Room 3 (GBR 103), 1F 안정남(한림의대)
08:30~09:00 CKD 2024 KDIGO Essentials: Definition, CGA Staging, and Risk-Based Care Room 4 (203), 2F 강석휘(영남의대)
09:00~09:30 Cardiovascular–Kidney–Metabolic (CKM) Syndrome in CKD: Pathways and Therapeutic Implications Room 4 (203), 2F 문주영(강동경희대학교병원)
09:30~10:00 Genetic Testing in CKD: Who to Test, When, and How to Act Room 4 (203), 2F 이범희(서울아산병원)
10:00~10:30 Glycemic Targets and Monitoring in CKD: from A1c to CGM/Time-In-Range Room 4 (203), 2F 배은희(전남의대)
10:40~11:10 Blood Pressure Targets and Management in CKD: from Monitoring to Multidrug Strategies Room 4 (203), 2F 고은실(가톨릭의대)
11:10~11:40 Best Practice in Diabetic Kidney Disease: Multidrug Strategies and Target Setting Room 4 (203), 2F 김일영(부산의대)
11:40~12:10 Integrated Management of CKD–MBD: Phosphate, PTH, Vitamin D, and Phosphate Binders Room 4 (203), 2F 김지은(고려대학교 구로병원)
12:10~12:40 CKD in Older Adults: Dialysis Vs Conservative Care and Shared Decision-Making Room 4 (203), 2F 권순효(순천향의대)